LIT™ in Sepsis
Current diagnostic methods rely on non-specific tests and clinical signs, such as elevated heart rate, fever, and low blood pressure. Developing a rapid bedside test of immune system function could indicate the need for urgent diagnosis and treatment.Every minute counts in the fight against sepsis
LIT™ has been shown to be more responsive for monitoring clinical progression compared to current biomarkers.
Global burden
There are approximately 49 million cases of sepsis each year. Sepsis kills 11 million people each year, which accounted for almost 20% of all global deaths. $62 billion estimated annual cost*.
The global sepsis diagnostics market size was valued at USD 685.4 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.7% from 2023 to 2030**.
Our new 10-minute test can make a life-saving difference, preventing an 8% increase in mortality caused by just one hour of delay in diagnosis*.
Challenges in the US
Spending on sepsis was estimated at US $20 billion (5.2% of hospital costs) in 2011. Sepsis is the number one cost of hospitalization in the U.S***.
30% of the deaths and cost can be prevented through propriate early detection*.
*Data from World Health Organization July 2023
**Sepsis Diagnostics Market Size, Share & Trends Analysis Report from Grand View Research
***Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level. Crit Care Med. 2018 Dec
